Literature DB >> 26094006

High accuracy of family history of melanoma in Danish melanoma cases.

Karin A W Wadt1, Krzysztof T Drzewiecki2, Anne-Marie Gerdes3.   

Abstract

The incidence of melanoma in Denmark has immensely increased over the last 10 years making Denmark a high risk country for melanoma. In the last two decades multiple public campaigns have sought to increase the awareness of melanoma. Family history of melanoma is a known major risk factor but previous studies have shown that self-reported family history of melanoma is highly inaccurate. These studies are 15 years old and we wanted to examine if a higher awareness of melanoma has increased the accuracy of self-reported family history of melanoma. We examined the family history of 181 melanoma probands who reported 199 cases of melanoma in relatives, of which 135 cases where in first degree relatives. We confirmed the diagnosis of melanoma in 77% of all relatives, and in 83% of first degree relatives. In 181 probands we validated the negative family history of melanoma in 748 first degree relatives and found only 1 case of melanoma which was not reported in a 3 case melanoma family. Melanoma patients in Denmark report family history of melanoma in first and second degree relatives with a high level of accuracy with a true positive predictive value between 77 and 87%. In 99% of probands reporting a negative family history of melanoma in first degree relatives this information is correct. In clinical practice we recommend that melanoma diagnosis in relatives should be verified if possible, but even unverified reported melanoma cases in relatives should be included in the indication of genetic testing and assessment of melanoma risk in the family.

Entities:  

Keywords:  Family cancer history; Melanoma; Validation

Mesh:

Year:  2015        PMID: 26094006     DOI: 10.1007/s10689-015-9820-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  13 in total

1.  Bias in the assessment of family history of melanoma and its association with dysplastic nevi in a case-control study.

Authors:  M A Weinstock; G L Brodsky
Journal:  J Clin Epidemiol       Date:  1998-12       Impact factor: 6.437

2.  Accuracy of case-reported family history of melanoma in Queensland, Australia.

Authors:  J F Aitken; P Youl; A Green; R MacLennan; N G Martin
Journal:  Melanoma Res       Date:  1996-08       Impact factor: 3.599

3.  Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients?

Authors:  H Eerola; C Blomqvist; E Pukkala; S Pyrhönen; H Nevanlinna
Journal:  Eur J Cancer       Date:  2000-06       Impact factor: 9.162

Review 4.  Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history.

Authors:  Harvey J Murff; David R Spigel; Sapna Syngal
Journal:  JAMA       Date:  2004-09-22       Impact factor: 56.272

5.  Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results.

Authors:  H M Verkooijen; G Fioretta; P O Chappuis; G Vlastos; A P Sappino; S Benhamou; C Bouchardy
Journal:  Ann Oncol       Date:  2004-02       Impact factor: 32.976

Review 6.  Selection criteria for genetic assessment of patients with familial melanoma.

Authors:  Sancy A Leachman; John Carucci; Wendy Kohlmann; Kimberly C Banks; Maryam M Asgari; Wilma Bergman; Giovanna Bianchi-Scarrà; Teresa Brentnall; Brigitte Bressac-de Paillerets; William Bruno; Clara Curiel-Lewandrowski; Femke A de Snoo; Tadeusz Debniak; Marie-France Demierre; David Elder; Alisa M Goldstein; Jane Grant-Kels; Allan C Halpern; Christian Ingvar; Richard F Kefford; Julie Lang; Rona M MacKie; Graham J Mann; Kurt Mueller; Julia Newton-Bishop; Håkan Olsson; Gloria M Petersen; Susana Puig; Darrell Rigel; Susan M Swetter; Margaret A Tucker; Emanuel Yakobson; John A Zitelli; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2009-10       Impact factor: 11.527

7.  Familial and attributable risks in cutaneous melanoma: effects of proband and age.

Authors:  Kari Hemminki; Hong Zhang; Kamila Czene
Journal:  J Invest Dermatol       Date:  2003-02       Impact factor: 8.551

Review 8.  Genetics: what advice for patients who present with a family history of melanoma?

Authors:  Julia A Newton Bishop; Nelleke A Gruis
Journal:  Semin Oncol       Date:  2007-12       Impact factor: 4.929

9.  POT1 loss-of-function variants predispose to familial melanoma.

Authors:  Carla Daniela Robles-Espinoza; Mark Harland; Andrew J Ramsay; Lauren G Aoude; Víctor Quesada; Zhihao Ding; Karen A Pooley; Antonia L Pritchard; Jessamy C Tiffen; Mia Petljak; Jane M Palmer; Judith Symmons; Peter Johansson; Mitchell S Stark; Michael G Gartside; Helen Snowden; Grant W Montgomery; Nicholas G Martin; Jimmy Z Liu; Jiyeon Choi; Matthew Makowski; Kevin M Brown; Alison M Dunning; Thomas M Keane; Carlos López-Otín; Nelleke A Gruis; Nicholas K Hayward; D Timothy Bishop; Julia A Newton-Bishop; David J Adams
Journal:  Nat Genet       Date:  2014-03-30       Impact factor: 38.330

10.  Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.

Authors:  Lauren G Aoude; Antonia L Pritchard; Carla Daniela Robles-Espinoza; Karin Wadt; Mark Harland; Jiyeon Choi; Michael Gartside; Víctor Quesada; Peter Johansson; Jane M Palmer; Andrew J Ramsay; Xijun Zhang; Kristine Jones; Judith Symmons; Elizabeth A Holland; Helen Schmid; Vanessa Bonazzi; Susan Woods; Ken Dutton-Regester; Mitchell S Stark; Helen Snowden; Remco van Doorn; Grant W Montgomery; Nicholas G Martin; Thomas M Keane; Carlos López-Otín; Anne-Marie Gerdes; Håkan Olsson; Christian Ingvar; Ake Borg; Nelleke A Gruis; Jeffrey M Trent; Göran Jönsson; D Timothy Bishop; Graham J Mann; Julia A Newton-Bishop; Kevin M Brown; David J Adams; Nicholas K Hayward
Journal:  J Natl Cancer Inst       Date:  2014-12-13       Impact factor: 13.506

View more
  3 in total

1.  Initial clinical validation of Health Heritage, a patient-facing tool for personal and family history collection and cancer risk assessment.

Authors:  Leigh A Baumgart; Kristen J Vogel Postula; William A Knaus
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

2.  Low accuracy of self-reported family history of melanoma in high-risk patients.

Authors:  Nicholas D Flint; Michael D Bishop; Tristan C Smart; Jennifer L Strunck; Kenneth M Boucher; Douglas Grossman; Aaron M Secrest
Journal:  Fam Cancer       Date:  2021-01       Impact factor: 2.375

3.  Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma.

Authors:  Thomas P Potjer; Tara W J van der Grinten; Inge M M Lakeman; Sander H Bollen; Mar Rodríguez-Girondo; Mark M Iles; Jennifer H Barrett; Lambertus A Kiemeney; Nelleke A Gruis; Christi J van Asperen; Nienke van der Stoep
Journal:  J Med Genet       Date:  2020-09-29       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.